BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

675 related articles for article (PubMed ID: 22963440)

  • 1. P2X7 receptors: channels, pores and more.
    Volonté C; Apolloni S; Skaper SD; Burnstock G
    CNS Neurol Disord Drug Targets; 2012 Sep; 11(6):705-21. PubMed ID: 22963440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P2X7 Receptors Amplify CNS Damage in Neurodegenerative Diseases.
    Illes P
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32825423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The P2X7 purinergic receptor: from physiology to neurological disorders.
    Skaper SD; Debetto P; Giusti P
    FASEB J; 2010 Feb; 24(2):337-45. PubMed ID: 19812374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. P2X7 receptor: an emerging target in central nervous system diseases.
    Sperlágh B; Illes P
    Trends Pharmacol Sci; 2014 Oct; 35(10):537-47. PubMed ID: 25223574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P2X7 receptor antagonism prevents IL-1β release from salivary epithelial cells and reduces inflammation in a mouse model of autoimmune exocrinopathy.
    Khalafalla MG; Woods LT; Camden JM; Khan AA; Limesand KH; Petris MJ; Erb L; Weisman GA
    J Biol Chem; 2017 Oct; 292(40):16626-16637. PubMed ID: 28798231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure, function and techniques of investigation of the P2X7 receptor (P2X7R) in mammalian cells.
    Di Virgilio F; Jiang LH; Roger S; Falzoni S; Sarti AC; Vultaggio-Poma V; Chiozzi P; Adinolfi E
    Methods Enzymol; 2019; 629():115-150. PubMed ID: 31727237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A central role for P2X7 receptors in human microglia.
    Janks L; Sharma CVR; Egan TM
    J Neuroinflammation; 2018 Nov; 15(1):325. PubMed ID: 30463629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ethanol differentially modulates P2X4 and P2X7 receptor activity and function in BV2 microglial cells.
    Asatryan L; Ostrovskaya O; Lieu D; Davies DL
    Neuropharmacology; 2018 Jan; 128():11-21. PubMed ID: 28943285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P2X7 receptor-stimulation causes fever via PGE2 and IL-1β release.
    Barberà-Cremades M; Baroja-Mazo A; Gomez AI; Machado F; Di Virgilio F; Pelegrín P
    FASEB J; 2012 Jul; 26(7):2951-62. PubMed ID: 22490780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-187-3p mimic alleviates ischemia-reperfusion-induced pain hypersensitivity through inhibiting spinal P2X7R and subsequent mature IL-1β release in mice.
    Li XQ; Yu Q; Zhang ZL; Sun XJ; Ma H
    Brain Behav Immun; 2019 Jul; 79():91-101. PubMed ID: 31100367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional P2X
    Prades S; Heard G; Gale JE; Engel T; Kopp R; Nicke A; Smith KE; Jagger DJ
    J Neurosci; 2021 Mar; 41(12):2615-2629. PubMed ID: 33563723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New Inhibitory Effects of Cilnidipine on Microglial P2X7 Receptors and IL-1β Release: An Involvement in its Alleviating Effect on Neuropathic Pain.
    Yamashita T; Kamikaseda S; Tanaka A; Tozaki-Saitoh H; Caaveiro JMM; Inoue K; Tsuda M
    Cells; 2021 Feb; 10(2):. PubMed ID: 33670748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P2X7R large pore is partially blocked by pore forming proteins antagonists in astrocytes.
    Faria RX; Reis RA; Ferreira LG; Cezar-de-Mello PF; Moraes MO
    J Bioenerg Biomembr; 2016 Jun; 48(3):309-24. PubMed ID: 26830892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P2X7 receptor antagonists: a patent review (2010-2015).
    Park JH; Kim YC
    Expert Opin Ther Pat; 2017 Mar; 27(3):257-267. PubMed ID: 27724045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physiological roles and potential therapeutic applications of the P2X7 receptor in inflammation and pain.
    Alves LA; Bezerra RJ; Faria RX; Ferreira LG; da Silva Frutuoso V
    Molecules; 2013 Sep; 18(9):10953-72. PubMed ID: 24013409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The phenothiazine-class antipsychotic drugs prochlorperazine and trifluoperazine are potent allosteric modulators of the human P2X7 receptor.
    Hempel C; Nörenberg W; Sobottka H; Urban N; Nicke A; Fischer W; Schaefer M
    Neuropharmacology; 2013 Dec; 75():365-79. PubMed ID: 23954492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of P2X7 receptor on tumorigenesis and its pharmacological properties.
    Zhang WJ; Hu CG; Zhu ZM; Luo HL
    Biomed Pharmacother; 2020 May; 125():109844. PubMed ID: 32004973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The P2X7 receptor: A main player in inflammation.
    Adinolfi E; Giuliani AL; De Marchi E; Pegoraro A; Orioli E; Di Virgilio F
    Biochem Pharmacol; 2018 May; 151():234-244. PubMed ID: 29288626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P2X7 receptor cross-talk regulates ATP-induced pannexin 1 internalization.
    Boyce AKJ; Swayne LA
    Biochem J; 2017 Jun; 474(13):2133-2144. PubMed ID: 28495860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The potential of P2X7 receptors as a therapeutic target, including inflammation and tumour progression.
    Burnstock G; Knight GE
    Purinergic Signal; 2018 Mar; 14(1):1-18. PubMed ID: 29164451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.